I-DOX MEDICO LEGAL LIMITED

Company Registration Number:
10953342 (England and Wales)

Unaudited statutory accounts for the year ended 30 September 2024

Period of accounts

Start date: 30 September 2023

End date: 30 September 2024

I-DOX MEDICO LEGAL LIMITED

Contents of the Financial Statements

for the Period Ended 30 September 2024

Company Information - 3
Report of the Directors - 4
Profit and Loss Account - 5
Balance sheet - 6
Additional notes - 8
Balance sheet notes - 12

I-DOX MEDICO LEGAL LIMITED

Company Information

for the Period Ended 30 September 2024




Director: Mr M Ashraf
Registered office: Halifax House 93-101
Bridge Street
Manchester
England
M3 2GX
Company Registration Number: 10953342 (England and Wales)

I-DOX MEDICO LEGAL LIMITED

Directors' Report Period Ended 30 September 2024

The directors present their report with the financial statements of the company for the period ended 30 September 2024

Principal Activities

The principal activity of the company during the year continued to be that of legal services

Directors

The directors shown below have held office during the whole of the period from 30 September 2023 to 30 September 2024
Mr M Ashraf

This report was approved by the board of directors on 6 May 2025
And Signed On Behalf Of The Board By:

Name: Mr M Ashraf
Status: Director

I-DOX MEDICO LEGAL LIMITED

Profit and Loss Account

for the Period Ended 30 September 2024


Notes

2024
£

2023
£
Turnover 1,017,421 1,074,879
Cost of sales ( 376,406 ) ( 704,884 )
Gross Profit or (Loss) 641,015 369,995
Administrative Expenses ( 500,282 ) ( 159,311 )
Operating Profit or (Loss) 140,733 210,684
Interest Receivable and Similar Income 973 1,777
Interest Payable and Similar Charges - ( 1,186 )
Profit or (Loss) Before Tax 141,706 211,275
Tax on Profit ( 32,382 ) ( 46,212 )
Profit or (Loss) for Period 109,324 165,063

The notes form part of these financial statements

I-DOX MEDICO LEGAL LIMITED

Balance sheet

As at 30 September 2024


Notes

2024
£

2023
£
Fixed assets
Tangible assets: 5 46,393
Total fixed assets: 46,393
Current assets
Debtors: 6 455,813 513,735
Cash at bank and in hand: 255,481 292,574
Total current assets: 711,294 806,309
Creditors: amounts falling due within one year: 7 ( 394,078 ) ( 535,416 )
Net current assets (liabilities): 317,216 270,893
Total assets less current liabilities: 363,609 270,893
Creditors: amounts falling due after more than one year: 8 ( 37,757 )
Accruals and deferred income: ( 13,148 ) ( 17,352 )
Total net assets (liabilities): 312,704 253,541

The notes form part of these financial statements

I-DOX MEDICO LEGAL LIMITED

Balance sheet continued

As at 30 September 2024


Notes

2024
£

2023
£
Capital and reserves
Called up share capital: 100 100
Profit and loss account: 312,604 253,441
Shareholders funds: 312,704 253,541

For the year ending 30 September 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 6 May 2025
And Signed On Behalf Of The Board By:

Name: Mr M Ashraf
Status: Director

The notes form part of these financial statements

I-DOX MEDICO LEGAL LIMITED

Notes to the Financial Statements

for the Period Ended 30 September 2024

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

    Turnover policy

    Turnover is recognised at the fair value of the consideration received or receivable for goods and services
    provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair
    value of consideration takes into account trade discounts, settlement discounts and volume rebates.
    When cash inflows are deferred and represent a financing arrangement, the fair value of the consideration is
    the present value of the future receipts. The difference between the fair value of the consideration and the
    nominal amount received is recognised as interest income.
    Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the
    goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured
    reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the
    costs incurred or to be incurred in respect of the transaction can be measured reliably.
    Revenue from contracts for the provision of professional services is recognised by reference to the stage of
    completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The
    stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff
    rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue
    is recognised only to the extent of the expenses recognised that it is probable will be recovered.

I-DOX MEDICO LEGAL LIMITED

Notes to the Financial Statements

for the Period Ended 30 September 2024

  • 2. Employees


    2024

    2023
    Average number of employees during the period 5 5

I-DOX MEDICO LEGAL LIMITED

Notes to the Financial Statements

for the Period Ended 30 September 2024

  • 3. Off balance sheet disclosure

    No

I-DOX MEDICO LEGAL LIMITED

Notes to the Financial Statements

for the Period Ended 30 September 2024

4. Dividends


2024
£

2023
£
Dividends paid 49,000 76,000

I-DOX MEDICO LEGAL LIMITED

Notes to the Financial Statements

for the Period Ended 30 September 2024

5. Tangible assets

Motor vehicles Total
Cost £ £
At 30 September 2023 - -
Additions 50,340 50,340
Disposals - -
Revaluations - -
Transfers - -
At 30 September 2024 50,340 50,340
Depreciation
At 30 September 2023 - -
Charge for year 3,947 3,947
On disposals - -
Other adjustments - -
At 30 September 2024 3,947 3,947
Net book value
At 30 September 2024 46,393 46,393
At 29 September 2023 - -

I-DOX MEDICO LEGAL LIMITED

Notes to the Financial Statements

for the Period Ended 30 September 2024

6. Debtors


2024
£

2023
£
Trade debtors 12,512
Other debtors 455,813 501,223
Total 455,813 513,735

I-DOX MEDICO LEGAL LIMITED

Notes to the Financial Statements

for the Period Ended 30 September 2024

7.Creditors: amounts falling due within one year note


2024
£

2023
£
Trade creditors 213,712 261,242
Taxation and social security 180,366 274,174
Total 394,078 535,416

I-DOX MEDICO LEGAL LIMITED

Notes to the Financial Statements

for the Period Ended 30 September 2024

8.Creditors: amounts falling due after more than one year


2024
£

2023
£
Amounts due under finance leases and hire purchase contracts 37,757
Total 37,757